+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society



A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society



Menopause 7(2): 76-86



Menopause is associated with physiologic changes that may have negative effects on quality of life in some women and/or that may increase morbidity and mortality secondary to osteoporosis and/or coronary heart disease. Estrogen replacement therapy (ERT) and combined estrogen/progestogen therapy (hormone replacement therapy [HRT]) play an important role in reducing these negative effects. The North American Menopause Society (NAMS) sought to develop treatment algorithms that could assist the clinician in deciding whether to recommend ERT/HRT to postmenopausal women. NAMS held a closed conference of experts to develop a decision tree that outlined the rational use of ERT/HRT in postmenopausal women on the basis of risks versus benefits. The proceedings of the conference were used to assist the NAMS Board of Trustees in developing this consensus opinion of the Society. On the basis of the conference proceedings, NAMS developed three algorithms for the clinician to use as a tool in deciding whether to recommend ERT/HRT to a woman who is postmenopausal: (1) menopause-related symptoms, (2) cardiovascular risk, and (3) osteoporosis risk. The goal of ERT/HRT is to enhance women's quality of life as well as to reduce the risks of death and disability associated with osteoporosis and coronary heart disease. The decision to initiate ERT/HRT must be individualized according to each woman's needs. This decision tree for ERT/HRT presents a rational approach to decision making on the basis of the principles of care; details of specific therapeutic interventions will change as data from clinical trials are presented.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045055875

Download citation: RISBibTeXText

PMID: 10746889


Related references

Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society. Menopause 7(2): 87-95, 2000

A Decision Tree for the Use of Estrogen Replacement Therapy or Hormone Replacement Therapy in Postmenopausal Women. Menopause 7(2): 76-86, 2000

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Journal of Cardiovascular Medicine 10(1): 85-92, 2009

Canadian consensus on hormone replacement therapy. Estrogen and progestin use in postmenopausal women. Canadian Family Physician Medecin de Famille Canadien 49: 188-191, 2003

Effects of Menopause and Estrogen Replacement Therapy or Hormone Replacement Therapy in Women With Diabetes Mellitus. Menopause 7(2): 87-95, 2000

Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I. Minerva Ginecologica 59(3): 205-214, 2007

Serum levels of some fat metabolism parameters in women with surgical menopause-users of sequential estrogen replacement therapy and nonusers of hormone replacement therapy. Clinical Chemistry & Laboratory Medicine 37(SPEC Suppl. ): S275, 1999

The role of calcium in peri- and postmenopausal women: consensus opinion of The North American Menopause Society. Menopause 8(2): 84-95, 2001

Serum levels of some fat metabolism parameters in women with surgical menopause-users of sequential estrogen/progestogen replacement therapy and nonusers of hormone replacement therapy. Clinical Chemistry & Laboratory Medicine 37(SPEC Suppl. ): S191, 1999

The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause 7(3): 143-148, 2000

Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women. Clinical Calcium 17(9): 1315-1324, 2007

Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause 10(2): 113-132, 2003

Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy. Journal of the British Menopause Society 11(4): 152-156, 2005

Managing the menopause - British Menopause Society Council consensus statement on hormone replacement therapy. Journal of the British Menopause Society 9(3): 129-131, 2003

Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II. Minerva Ginecologica 59(3): 215-222, 2007